🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 00430K402 (prev. 00430K105 )
- Market Cap
- Small Cap
- Previous Symbol
- ACST (changed 10/28/2024)
- Previous Name
- Acasti Pharma Inc.
Business: Grace Therapeutics, Inc. is a biopharmaceutical innovator focused on the research, development and commercialization of prescription drugs using omega-3 fatty acids derived from krill oil.
Notes: October 14, 2015 -- Acasti Pharma, Inc. (ACST) will effect a one for ten (1-10) reverse split of its outstanding Class A common stock. The reverse split will be effective at the opening of business on Thursday, October 15, 2015. In conjunction with the reverse split, the CUSIP number will change to 00430K402.
Company Contact
- CEO
- Prashant Kohli
- CFO
- Robert J. DelAversano
- Headquarters
- 103 Carnegie Center Suite 300, Princeton, NJ 08540
- Phone
- 818-839-4378
- Fax
- 450-686-2505
- Investor Relations
- Mike Moyer, LifeSci Advisors · 617-308-4306 · mmoyer@lifesciadvisors.com